10 employees
NX PharmaGen acquires, develops, and monetizes mature clinical-stage breakthrough technologies.
2010
$3.5M
from 2 investors over 2 rounds
NX PharmaGen Inc. raised $773K on June 24, 2013
Investors: Keyhorse Capital
NX PharmaGen Inc. raised $3.5M on January 1, 2012